BFS-Neostigmine 0.25
Basic Information
Category
Subcategory & Sub-subcategory
Trade Type
Sell
Product Name
BFS-Neostigmine 0.25
Details
Substance
Manufacturer(s)
Registered Market
Specifications
- Dosage Form: Solution injection
- Packaging: Box 10 ampoule x 1 mL; box 20 ampoule x 1 mL; box 50 ampoule x 1 mL
- Strength: 0,25mg/ml
- Standards: In-house standard
- Shelf Life: 36 month
Documents
Drug Marketing Authorization Number
Document No.: 893114703224
Issue Date: Aug 1, 2024
Expiry Date: Aug 1, 2027
Note: 550/QĐ-QLD | 206
Ratings
(0)
(0)
(0)
(0)
(0)
Comments
Filters:
Sort by:
No comments available.
Matched Products & Services
B2B matches based on trade type, category, specifications & price range
Similar Products & Services
Products & Services related to what you're viewing
People Also Viewed
Other products & services viewed by people who looked at this product
Leave your rating & comment